Ginkgo Bioworks Holdings (DNA) Accumulated Depreciation (2020 - 2023)

Ginkgo Bioworks Holdings (DNA) has 4 years of Accumulated Depreciation data on file, last reported at $118.5 million in Q2 2023.

• For the quarter ending Q2 2023, Accumulated Depreciation rose 51.47% year-over-year to $118.5 million; the trailing twelve-month figure through Jun 2023 stood at $118.5 million (up 51.47% YoY), and the FY2022 full-year result was $92.8 million, up 51.93% from the prior year.
• Accumulated Depreciation for Q2 2023 stood at $118.5 million, up from $107.3 million in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $118.5 million in Q2 2023 and bottomed at $33.8 million in Q4 2020.
• The 4-year median for Accumulated Depreciation is $78.2 million (2022), against an average of $77.6 million.
• The widest annual swing landed in 2021, when Accumulated Depreciation jumped 80.74%; it then soared 51.47% in 2023.
• A 4-year view of Accumulated Depreciation shows it stood at $33.8 million in 2020, then jumped by 80.74% to $61.1 million in 2021, then jumped by 51.93% to $92.8 million in 2022, then gained by 27.72% to $118.5 million in 2023.
• The last three Accumulated Depreciation figures came in at $118.5 million (Q2 2023), $107.3 million (Q1 2023), and $92.8 million (Q4 2022), per Business Quant data.

Peer Comparison